Salivary Antioxidant Capacity Before and After Complete Dental Rehabilitation

Sponsor
Riyadh Colleges of Dentistry and Pharmacy (Other)
Overall Status
Completed
CT.gov ID
NCT03432728
Collaborator
(none)
40
1
23.2
1.7

Study Details

Study Description

Brief Summary

Salivary samples were obtained from 20 children in their fifth year of life diagnosed S-ECC and 20 age and sex matched controls. Complete dental rehabilitation under general anesthesia was performed for the 20 children with S-ECC, and follow up salivary samples were obtained one week and three months post operatively. The TAC was measured using a commercially available Oxygen Radical Absorbance Antioxidant Assay measurement kit (Zen-Bio ORAC™, AMS Biotechnology, Abington UK).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dental rehabilitation under general anesthesia

Detailed Description

Background: The association of total salivary antioxidant capacity (TAC) to severe early childhood caries (S-ECC) has been studied in the past. It is not clear if TAC is an indicator of the inflammatory response to the lesion or a marker of the disease.

Aim: This study aimed to measure the salivary TAC levels in children with early childhood caries before and after dental treatment and compare the results to caries free children.

Methodology: Salivary samples were obtained from 20 children in their fifth year of life diagnosed S-ECC and 20 age and gendersex matched controls. Complete dental rehabilitation under general anesthesia was performed for the 20 children with S-ECC, and follow up salivary samples were obtained one week and three months post operatively. The TAC was measured using a commercially available Oxygen Radical Absorbance Antioxidant Assay measurement kit (Zen-Bio ORAC™, AMS Biotechnology, Abington UK).

Study Design

Study Type:
Observational
Actual Enrollment :
40 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Salivary Antioxidant Capacity of Children With Severe Early Childhood Caries (S-ECC) Before and After Complete Dental Rehabilitation
Actual Study Start Date :
Jan 25, 2016
Actual Primary Completion Date :
Jan 28, 2017
Actual Study Completion Date :
Dec 31, 2017

Arms and Interventions

Arm Intervention/Treatment
S-ECC

Children in their fifth year of life with severe early childhood caries Children selected will require complete dental rehabilitation under general anesthesia All enrolled children will receive treatment of all dental carious lesions under general anesthesia

Procedure: Dental rehabilitation under general anesthesia
Dental treatment of all teeth affected by dental caries in a single visit under general anesthesia

Control

Children age and sex matched with the S-ECC group who are free of dental caries

Outcome Measures

Primary Outcome Measures

  1. Change in TAC after one week [One week]

    Change in Total Salivary Antioxidant Capacity of children from baseline to one week after treatment

  2. Change in TAC after Three months [Three months]

    Change in Total Salivary Antioxidant Capacity of children from baseline to three months after treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Months to 72 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Medically fit children

  • Age below 71 months

  • Test group - to be diagnosed with severe ECC

  • Control group - to be caries free

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Riyadh Colleges of Dentistry and Pharmacy Riyadh Saudi Arabia

Sponsors and Collaborators

  • Riyadh Colleges of Dentistry and Pharmacy

Investigators

  • Principal Investigator: Sharat C Pani, MDS, Riyadh Colleges of Dentistry and Pharmacy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Sharat Pani, Program Director - Pediatric Dentistry, Riyadh Colleges of Dentistry and Pharmacy
ClinicalTrials.gov Identifier:
NCT03432728
Other Study ID Numbers:
  • FPGRP/ /43435005/126
First Posted:
Feb 14, 2018
Last Update Posted:
Feb 14, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Sharat Pani, Program Director - Pediatric Dentistry, Riyadh Colleges of Dentistry and Pharmacy
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2018